MoonLake Immunotherapeutics Share Price & Technical Analysis
MLTX · $18.19 (-1.52%)
Healthcare / Biotechnology
$18.19
-1.52%
MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplant…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
11% return in May, 5% avg return in past 3 year May month.
37% return in 2026, 71% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 19% | 8% | 9% | -9% | 11% | – | – | – | – | – | – | – | 37% |
| 25 | -15% | -7% | -6% | 8% | -7% | 20% | 7% | 11% | -87% | 44% | 33% | -3% | -2% |
| 24 | -6% | -14% | 1% | -19% | -1% | 7% | -5% | 12% | 8% | -8% | 16% | 0% | -9% |
| 23 | 12% | 61% | 10% | -1% | 21% | 88% | 16% | -5% | 9% | -9% | -15% | 38% | 224% |
| 22 | 0% | 0% | 11% | -39% | 24% | -22% | 21% | 31% | -4% | 3% | 22% | 6% | 53% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.32B
P/E ratio
—
52W high
$62.75
52W low
$5.95
Volume
6,53,756
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is MoonLake Immunotherapeutics share price today?
- MoonLake Immunotherapeutics (MLTX) last traded around $18.19 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MLTX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MLTX. Download the app for real-time alerts.
- How can I analyze MoonLake Immunotherapeutics stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.